Deep Tech · VC Firm · Active
DCVC
DCVC (Data Collective) is a Palo Alto-based deep-tech VC founded 2011 by Matthew Ocko and Zachary Bogue, with $4B AUM across DCVC V ($725M, 2024 — roughly 2x prior vintage), DCVC Bio III ($400M…
Investment thesis
DCVC (Data Collective) is a Palo Alto-based deep-tech VC founded 2011 by Matthew Ocko and Zachary Bogue, with $4B AUM across DCVC V ($725M, 2024 — roughly 2x prior vintage), DCVC Bio III ($400M oversubscribed), and DCVC Climate. Invests seed to growth in AI, materials, space, defense, climate, biotech, industrials. Cheques $3-50M.
Quantum thesis is "picks and shovels" explicit: rather than betting across hardware platforms, DCVC backs the enabling layer. Lead investor in Q-CTRL (Sydney, quantum control firmware + quantum navigation; $59M Series B extension 2024 bringing total to $113M; April 2025 achieved 500km GPS-denied navigation at 150m accuracy, then Defense Innovation Unit contract with Lockheed Martin). Rigetti (superconducting, public via SPAC 2022) is the exception to the picks-and-shovels rule. Recent adds include Lightsynq (quantum interconnect).
Value-add: one of the deepest technical diligence benches in VC. Partner James Hardiman leads quantum; Operating Partner Prineha Narang (UCLA professor) provides academic depth. Strong DOD/IC dual-use channel.
Differentiated by coherent public thesis ("infrastructure over platforms") plus unmatched dual-use government and defense networks for quantum sensing/navigation.
Anti-thesis
The patterns that trigger a fast no with this fund.
- Pure-play single-modality qubit bets without a multi-architecture or picks and shovels angle: DCVC's 2024 DTOR explicitly states they invest in the picks and shovels of the quantum stack
- Pre-product science projects without a near-term commercial wedge: Matt Ocko has framed quantum as entering a more disciplined phase where technical milestones, government scrutiny and architectural tradeoffs matter as much as ambition
- Teams lacking systems-level technical depth: Prineha Narang (UCLA, Operating Partner) screens for genuine quantum systems expertise and government / defence credibility
- Founders dismissive of error correction, US export controls or supply chain realities: DCVC now treats CHIPS, NDAA and Genesis Mission alignment as table stakes
- Hype-driven roadmaps promising commercial advantage in 2 to 3 years: DCVC publicly reset expectations after the 2024-2025 quantum stock cycle and prefers patient capital
- Cap tables incompatible with US national-security funding (DOE, DARPA, IARPA, In-Q-Tel), which DCVC actively pursues for portfolio companies
Notable quantum portfolio
Full portfolio →Reach out to DCVC
A cold email and a 1-page brief, ready in two clicks.